Annual Operating Expenses
$13.64 B
+$3.19 B+30.52%
31 December 2023
Summary:
Novo Nordisk A/S annual total operating expenses is currently $13.64 billion, with the most recent change of +$3.19 billion (+30.52%) on 31 December 2023. During the last 3 years, it has risen by +$5.69 billion (+71.52%). NVO annual operating expenses is now at all-time high.NVO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$3.86 B
-$739.32 M-16.08%
30 September 2024
Summary:
Novo Nordisk A/S quarterly total operating expenses is currently $3.86 billion, with the most recent change of -$739.32 million (-16.08%) on 30 September 2024. Over the past year, it has increased by +$630.26 million (+19.52%). NVO quarterly operating expenses is now -16.08% below its all-time high of $4.60 billion, reached on 30 June 2024.NVO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.5% | +19.5% |
| 3 y3 years | +71.5% | +70.0% |
| 5 y5 years | +83.3% | +110.9% |
NVO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +71.5% | -16.1% | +70.0% |
| 5 y | 5 years | at high | +83.9% | -16.1% | +129.3% |
| alltime | all time | at high | >+9999.0% | -16.1% | +2649.4% |
Novo Nordisk A/S Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.86 B(-16.1%) |
| June 2024 | - | $4.60 B(+33.8%) |
| Mar 2024 | - | $3.44 B(-18.1%) |
| Dec 2023 | $13.64 B(+30.5%) | $4.20 B(+30.0%) |
| Sept 2023 | - | $3.23 B(-2.1%) |
| June 2023 | - | $3.30 B(+13.3%) |
| Mar 2023 | - | $2.91 B(-6.9%) |
| Dec 2022 | $10.45 B(+12.2%) | $3.13 B(+27.0%) |
| Sept 2022 | - | $2.46 B(+2.3%) |
| June 2022 | - | $2.41 B(-0.1%) |
| Mar 2022 | - | $2.41 B(-15.2%) |
| Dec 2021 | $9.31 B(+17.1%) | $2.84 B(+25.1%) |
| Sept 2021 | - | $2.27 B(+10.1%) |
| June 2021 | - | $2.06 B(-2.3%) |
| Mar 2021 | - | $2.11 B(-14.2%) |
| Dec 2020 | $7.95 B(+7.2%) | $2.46 B(+20.7%) |
| Sept 2020 | - | $2.04 B(+21.0%) |
| June 2020 | - | $1.68 B(-6.5%) |
| Mar 2020 | - | $1.80 B(-19.7%) |
| Dec 2019 | $7.41 B(-0.3%) | $2.24 B(+22.4%) |
| Sept 2019 | - | $1.83 B(+3.6%) |
| June 2019 | - | $1.77 B(+12.4%) |
| Mar 2019 | - | $1.57 B(-28.1%) |
| Dec 2018 | $7.44 B(+8.4%) | $2.19 B(+21.5%) |
| Sept 2018 | - | $1.80 B(+3.4%) |
| June 2018 | - | $1.74 B(+2.5%) |
| Mar 2018 | - | $1.70 B(-19.0%) |
| Dec 2017 | $6.86 B(+0.0%) | $2.10 B(+28.8%) |
| Sept 2017 | - | $1.63 B(+1.5%) |
| June 2017 | - | $1.60 B(+4.5%) |
| Mar 2017 | - | $1.53 B(-21.3%) |
| Dec 2016 | $6.86 B(+9.1%) | $1.95 B(+16.8%) |
| Sept 2016 | - | $1.67 B(+0.7%) |
| June 2016 | - | $1.66 B(+5.1%) |
| Mar 2016 | - | $1.58 B(-18.2%) |
| Dec 2015 | $6.29 B(-11.3%) | $1.93 B(+18.0%) |
| Sept 2015 | - | $1.63 B(+2.9%) |
| June 2015 | - | $1.59 B(+40.3%) |
| Mar 2015 | - | $1.13 B(-41.0%) |
| Dec 2014 | $7.09 B(+5.0%) | $1.92 B(+5.2%) |
| Sept 2014 | - | $1.82 B(+7.6%) |
| June 2014 | - | $1.70 B(+4.4%) |
| Mar 2014 | - | $1.62 B(-18.7%) |
| Dec 2013 | $6.76 B(+11.5%) | $2.00 B(+24.9%) |
| Sept 2013 | - | $1.60 B(-0.7%) |
| June 2013 | - | $1.61 B(+3.2%) |
| Mar 2013 | - | $1.56 B(-12.4%) |
| Dec 2012 | $6.06 B(+3.4%) | $1.78 B(+24.8%) |
| Sept 2012 | - | $1.43 B(-1.6%) |
| June 2012 | - | $1.45 B(+3.2%) |
| Mar 2012 | - | $1.40 B(-9.5%) |
| Dec 2011 | $5.86 B | $1.55 B(+5.2%) |
| Sept 2011 | - | $1.47 B(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2011 | - | $1.47 B(+10.0%) |
| Mar 2011 | - | $1.34 B(-15.3%) |
| Dec 2010 | $5.38 B(+13.3%) | $1.58 B(+21.4%) |
| Sept 2010 | - | $1.30 B(+3.4%) |
| June 2010 | - | $1.26 B(-0.6%) |
| Mar 2010 | - | $1.27 B(-1.1%) |
| Dec 2009 | $4.75 B(+4.2%) | $1.28 B(+9.8%) |
| Sept 2009 | - | $1.17 B(+1.4%) |
| June 2009 | - | $1.15 B(+6.5%) |
| Mar 2009 | - | $1.08 B(-8.9%) |
| Dec 2008 | $4.56 B(+7.1%) | $1.19 B(+11.1%) |
| Sept 2008 | - | $1.07 B(-10.6%) |
| June 2008 | - | $1.20 B(+10.8%) |
| Mar 2008 | - | $1.08 B(-23.4%) |
| Dec 2007 | $4.25 B(+26.0%) | $1.41 B(+43.8%) |
| Sept 2007 | - | $980.12 M(+0.4%) |
| June 2007 | - | $976.42 M(+7.3%) |
| Mar 2007 | - | $909.60 M(-9.3%) |
| Dec 2006 | $3.38 B(+22.7%) | $1.00 B(+23.7%) |
| Sept 2006 | - | $810.71 M(-0.8%) |
| June 2006 | - | $816.89 M(+9.0%) |
| Mar 2006 | - | $749.20 M(-5.3%) |
| Dec 2005 | $2.75 B(+16.7%) | $791.30 M(+17.3%) |
| Sept 2005 | - | $674.82 M(+7.2%) |
| June 2005 | - | $629.58 M(-2.6%) |
| Mar 2005 | - | $646.34 M(-8.4%) |
| Dec 2004 | $2.36 B(+21.4%) | $705.23 M(+20.2%) |
| Sept 2004 | - | $586.68 M(+8.7%) |
| June 2004 | - | $539.86 M(+1.3%) |
| Mar 2004 | - | $533.09 M(-65.8%) |
| Dec 2003 | $1.94 B(+21.5%) | $1.56 B(+879.6%) |
| Sept 2003 | - | $158.89 M(+3.7%) |
| June 2003 | - | $153.19 M(+9.2%) |
| Mar 2003 | - | $140.33 M |
| Dec 2002 | $1.60 B(+9.4%) | - |
| Dec 2001 | $1.46 B(-3.3%) | - |
| Dec 2000 | $1.51 B(+6.5%) | - |
| Dec 1999 | $1.42 B(+5.5%) | - |
| Dec 1998 | $1.35 B(-10.7%) | - |
| Dec 1997 | $1.51 B(-0.3%) | - |
| Dec 1996 | $1.51 B(+5.6%) | - |
| Dec 1995 | $1.43 B(+15.7%) | - |
| Dec 1994 | $1.24 B(+67.0%) | - |
| Dec 1993 | $740.35 M(-36.2%) | - |
| Dec 1992 | $1.16 B(+103.8%) | - |
| Dec 1991 | $569.08 M(+11.4%) | - |
| Dec 1990 | $510.97 M(+33.0%) | - |
| Dec 1989 | $384.21 M(+30.5%) | - |
| Dec 1988 | $294.33 M(+12.3%) | - |
| Dec 1987 | $262.05 M(+841.0%) | - |
| Dec 1986 | $27.85 M(-78.3%) | - |
| Dec 1985 | $128.59 M(+12.6%) | - |
| Dec 1984 | $114.18 M | - |
FAQ
- What is Novo Nordisk A/S annual total operating expenses?
- What is the all time high annual operating expenses for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual operating expenses year-on-year change?
- What is Novo Nordisk A/S quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly operating expenses year-on-year change?
What is Novo Nordisk A/S annual total operating expenses?
The current annual operating expenses of NVO is $13.64 B
What is the all time high annual operating expenses for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total operating expenses is $13.64 B
What is Novo Nordisk A/S annual operating expenses year-on-year change?
Over the past year, NVO annual total operating expenses has changed by +$3.19 B (+30.52%)
What is Novo Nordisk A/S quarterly total operating expenses?
The current quarterly operating expenses of NVO is $3.86 B
What is the all time high quarterly operating expenses for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total operating expenses is $4.60 B
What is Novo Nordisk A/S quarterly operating expenses year-on-year change?
Over the past year, NVO quarterly total operating expenses has changed by +$630.26 M (+19.52%)